Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Medulloblastoma 4Central Nervous System Neoplasms 4Drug-Related Side Effects and Adverse Reactions 3Oligodendroglioma 2Glioma 2Brain Neoplasms 2Astrocytoma 2Thrombocytopenia 1Testicular Neoplasms 1Teratoma 1Sarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Lymphoma 1Liver Neoplasms 1Intraocular Lymphoma 1Hepatoblastoma 1Familial ependymoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3liposomal amphotericin B 2Thiotepa 2Rituximab 2Psychiatric Rehabilitation 2Fentanyl 2Etoposide 2Early Intervention, Educational 2Caspofungin 2Carboplatin 2sodium thiosulfate 1sargramostim 1pegfilgrastim 1imetelstat 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1Whole-Body Irradiation 1Voriconazole 1Radiotherapy 1Positron-Emission Tomography 1Pentetic Acid 1Pemetrexed 1Paclitaxel 1Oxycodone 1Nicotine 1Morphine 1Minocycline 1Methotrexate 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraocular Lymphoma × sodium thiosulfate × CNS × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡